Tafamidis is a medication primarily used to treat transthyretin amyloidosis (ATTR), a rare and progressive disease caused by the buildup of amyloid proteins in the body. These proteins can accumulate in various organs, leading to serious health issues, including heart and nerve damage. Tafamidis works by stabilizing the transthyretin protein, preventing it from misfolding and forming amyloid deposits.
Suvorexant is a prescription medication primarily used to treat insomnia, a condition characterized by difficulty falling asleep or staying asleep. Approved by the U.S. Food and Drug Administration (FDA) in 2014, Suvorexant belongs to a class of drugs known as orexin receptor antagonists. Unlike traditional sleep medications that often work by depressing the central nervous system, Suvorexant targets specific receptors in the brain that regulate wakefulness, promoting a more natural sleep cycle.
Sutimlimab is a monoclonal antibody designed to target and inhibit the activity of the complement system, specifically the C1s protein. This innovative medication is primarily used in the treatment of certain autoimmune conditions, particularly those associated with hemolytic anemia. By modulating the immune response, Sutimlimab helps to reduce the destruction of red blood cells, thereby improving patient outcomes.
Sunitinib is a targeted therapy medication primarily used in the treatment of certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific enzymes involved in the growth and spread of cancer cells. Sunitinib is FDA-approved for advanced or metastatic renal cell carcinoma (RCC) and for imatinib-resistant gastrointestinal stromal tumors (GIST).
Sunitinib is approved for several medical indications, including:
Sumatriptan is a medication primarily used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are specifically designed to alleviate the symptoms of migraines. Sumatriptan works by targeting specific receptors in the brain, helping to relieve headache pain and associated symptoms such as nausea and sensitivity to light and sound. It is available in various forms, including tablets, injections, and nasal sprays, making it a versatile option for those suffering from migraines.
Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily used to relieve pain, reduce inflammation, and lower fever. It is often prescribed for conditions such as arthritis, gout, and other musculoskeletal disorders. Sulindac works by inhibiting certain enzymes in the body that contribute to inflammation and pain, making it an effective option for managing various inflammatory conditions.
Sulfasalazine is a medication primarily used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, as well as rheumatoid arthritis. It is a 5-aminosalicylate (5-ASA) prodrug with anti-inflammatory properties, primarily acting locally in the gut via its 5-ASA metabolite and systemically in RA via sulfapyridine. Sulfasalazine is often prescribed to help manage symptoms and improve the quality of life for individuals suffering from these chronic conditions.
Sulfanilamide is a type of antibiotic that belongs to the sulfonamide class of drugs. It was one of the first antibiotics used to treat bacterial infections and has played a significant role in the history of medicine. Sulfanilamide works by inhibiting the growth of bacteria, making it effective against a variety of infections. Although its systemic use has been discontinued in favor of safer sulfonamides, topical formulations remain available in certain situations.
